Beyond Labels: Nutrivigilance, an Emerging Frontier and a New Activity in Drug Safety

Adverse drug reactions are unintended and harmful effects that occur at normal therapeutic doses. While pharmacovigilance systems are well established for conventional medicines, the increasing global use of nutraceuticals, including dietary supplements, herbal products, and functional foods, has raised significant safety concerns. These products are often perceived as inherently safe due to their natural origin and are frequently consumed without medical supervision. This review highlights the emerging concept of nutrivigilance as a critical extension of pharmacovigilance aimed at monitoring adverse effects associated with nutraceuticals. The analysis of available literature indicates substantial gaps in consumer awareness, widespread self-medication practices, and significant underreporting of adverse events related to nutraceutical use. Common adverse effects identified range from gastrointestinal disturbances and dermatological reactions to neurological and metabolic complications. Furthermore, the review identifies limitations in existing regulatory frameworks, particularly in post-marketing surveillance and standardization of nutraceutical products across different countries. The findings emphasize the urgent need for improved regulatory policies, enhanced awareness among healthcare professionals and consumers, and the establishment of robust reporting systems to ensure the safe and rational use of nutraceuticals. Nutrivigilance thus plays a vital role in bridging the gap between consumer practices and regulatory oversight, ultimately contributing to improved public health safety.

Authors

Institutions

Publication Details

Journal
Global Journal of Medical Pharmaceutical and Biomedical Update
Published
2026-06-30
DOI
https://doi.org/10.25259/gjmpbu_18_2026
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beyond Labels: Nutrivigilance, an Emerging Frontier and a New Activity in Drug Safety

Jiji Keezhipadathil, Mahendra Kumar Betur Jayappa
Global Journal of Medical Pharmaceutical and Biomedical Update
Pharmacovigilance and Adverse Drug Reactions
article

Beyond Labels: Nutrivigilance, an Emerging Frontier and a New Activity in Drug Safety

Jiji Keezhipadathil, Mahendra Kumar Betur Jayappa
article en

Abstract

Adverse drug reactions are unintended and harmful effects that occur at normal therapeutic doses. While pharmacovigilance systems are well established for conventional medicines, the increasing global use of nutraceuticals, including dietary supplements, herbal products, and functional foods, has raised significant safety concerns. These products are often perceived as inherently safe due to their natural origin and are frequently consumed without medical supervision. This review highlights the emerging concept of nutrivigilance as a critical extension of pharmacovigilance aimed at monitoring adverse effects associated with nutraceuticals. The analysis of available literature indicates substantial gaps in consumer awareness, widespread self-medication practices, and significant underreporting of adverse events related to nutraceutical use. Common adverse effects identified range from gastrointestinal disturbances and dermatological reactions to neurological and metabolic complications. Furthermore, the review identifies limitations in existing regulatory frameworks, particularly in post-marketing surveillance and standardization of nutraceutical products across different countries. The findings emphasize the urgent need for improved regulatory policies, enhanced awareness among healthcare professionals and consumers, and the establishment of robust reporting systems to ensure the safe and rational use of nutraceuticals. Nutrivigilance thus plays a vital role in bridging the gap between consumer practices and regulatory oversight, ultimately contributing to improved public health safety.

Global Journal of Medical Pharmaceutical and Biomedical UpdateVol. 21
Mandya Institute of Medical Sciences (IN)
Good health and well-being
Openalex Percentile: Top 8%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.